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The production of diffraction-quality crystals of Munc18c, a protein involved in
regulating vesicular exocytosis in mammals, is reported. The diffraction
resolution of Munc18c crystals was optimized by (i) cocrystallizing with a
peptide fragment of the Munc18c functional binding partner syntaxin4, (ii) using
nanolitre free-interface diffusion crystallization-screening chips and microlitre
hanging-drop vapour diffusion and (iii) applying a post-crystallization dehydra-
tion treatment. Crystals belonging to the cubic space group P213, with unit-cell
parameters a = b = c = 170.8 A˚,  =  =  = 90, were generated that diffract to
3.7 A˚ resolution on a laboratory X-ray source.
1. Introduction
Munc18c belongs to the Sec1/Munc18 (SM) family of proteins that
regulate vesicular exocytosis (Toonen & Verhage, 2003; Tellam et al.,
1995; Thurmond et al., 1998). The regulatory effects of SM proteins
are mediated through interactions with other exocytotic proteins,
principally the soluble N-ethylmaleimide sensitive factor attachment
protein receptors (SNAREs; Toonen & Verhage, 2003; Gallwitz &
Jahn, 2003). Munc18c is a difficult protein to handle; it cannot be
expressed in a stable form using bacterial expression systems,
although insect-cell expression using recombinant baculovirus does
generate protein of suitable stability for crystallization trials. The
expression and purification of N-terminally His-tagged Munc18c have
been reported in detail previously (Hu et al., 2003). We found that
Munc18c prepared in this manner crystallizes readily, but the
diffraction resolution of the 0.2 0.2 0.2 mm crystals is only10 A˚
using our laboratory X-ray source (data not shown). We therefore set
out to improve the diffraction resolution of Munc18c crystals using a
three-pronged approach.
Firstly, we cocrystallized Munc18c with a syntaxin4 peptide.
Syntaxin4 is the SNARE binding partner of Munc18c and we showed
recently that a peptide corresponding to the N-terminal 29 residues of
syntaxin4 is required for the interaction between these two proteins
(Latham et al., 2006). Secondly, our initial crystallization trials were
performed using a nanolitre free-interface diffusion screening chip in
order to minimize the amount of protein used during the screening
phase. The results were then scaled up to microlitre volumes using
hanging-drop vapour-diffusion experiments in order to obtain large
crystals of the protein–peptide complex. Thirdly, we employed a post-
crystallization dehydration treatment in order to improve diffraction
quality (Heras et al., 2003; Heras & Martin, 2005). Using these three
approaches, we generated crystals of dimensions 0.2  0.2  0.2 mm
that diffracted to a resolution of 3.7 A˚ using a laboratory X-ray
source.
2. Methods
2.1. Protein and peptide production
Recombinant N-terminally His-tagged mouse (Mus musculus)
Munc18c (73 493 Da, including the six-His tag), residues 1–592, was
produced from baculovirus-infected insect cells and purified as
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described previously (Hu et al., 2003). A peptide consisting of the
N-terminal 29 residues of mouse syntaxin4 (syntaxin41–29, 3392 Da)
was chemically synthesized as described previously (Latham et al.,
2006).
2.2. Crystallization
Purified N-terminally tagged Munc18c (in 25 mM HEPES pH 7.0,
150 mM NaCl, 2 mM -mercaptoethanol) was concentrated to
10 mg ml1 using an Amicon Ultra-4 centrifugal concentration device
with a molecular-weight cutoff of 10 kDa (Millipore, Billerica, MA,
USA). Munc18c was mixed with syntaxin41–29 to give a tenfold molar
excess of the peptide and the mixture was then incubated for 1–2 h on
ice. Cocrystallization trials were set up using free-interface diffusion
(Hansen et al., 2002) Topaz Screening 1.48 chips and Topaz Crystal-
lizer with the Topaz Optimix I screen consisting of 96 conditions
(Fluidigm, South San Francisco, CA, USA). After setup, the Topaz
chip was stored at 293 K in a temperature-controlled room and
examined manually with a Nikon SMZ/U light microscope every
2–3 d. Six conditions that produced small crystals in the Topaz chips
were translated to hanging-drop vapour-diffusion format according to
the manufacturer’s translation workbook and guide (Fluidigm, South
San Francisco, CA, USA). These six crystallization conditions were
optimized by screening different types of PEG at different concen-
trations, pH, protein concentrations and salt concentrations in 24-well
plates (pre-greased VDX plates from Hampton Research, San Diego,
CA, USA) at 293 K. Hanging drops of 2–4 ml (1–2 ml each of the
protein and reservoir solutions, respectively) were equilibrated over
500 ml reservoir solution. The optimized crystallization conditions
consisted of a reservoir solution containing 10–13% PEG 3350, 0.2M
magnesium acetate, 0.1M MES pH 6.5 and 50 mM magnesium
chloride. In both the Topaz chip and hanging-drop experiments,
crystals were observed after 3 d; the crystals in the hanging-drop
experiments grew to full size over a week. It is possible that crystals
appeared more quickly in the Topaz chips than in the hanging-drop
experiments, but the chips and vapour-diffusion experiments were
only checked every 2–3 d. Consequently, crystals were only observed
on the third day in both set-ups.
2.3. Diffraction
Crystals were evaluated for X-ray diffraction on a Rigaku FR-E
copper rotating-anode generator operating at 45 kV and 45 mA with
Osmic Confocal Max-Flux (HiRes2) optics. Reflections were
crystallization communications
Acta Cryst. (2007). F63, 524–528 Latham et al.  Munc18c–syntaxin41–29 complex 525
Figure 1
Munc18c crystallization. (a) Crystals of similar morphology formed in the protein wells of Topaz crystal chips in six related PEG crystallization conditions. Crystals from
condition 6 of the Optimix screen (Table 1) are shown. The crystallization components and approximate dimensions of the crystals for the six conditions are given in Table 1.
The crystal sizes vary from 10 to 40 mm in the longest dimension. (b) Crystallization conditions were translated from free-interface diffusion to hanging-drop vapour
diffusion. The crystal shown (longest dimension 200 mm) was grown by hanging-drop vapour diffusion in 12% PEG 3350, 0.2M magnesium acetate, 0.1MMES pH 6.5 and
50 mM magnesium chloride.
Table 1
Crystallization conditions.
1–6 refer to conditions producing crystals in the Topaz chip; condition 7 was used to produce crystals using hanging-drop vapour diffusion. The crystals produced from conditions 6 and 7
are shown in Fig. 1.
Crystallization conditions
Precipitant Buffer Salt Approximate crystal size† (mm)
1 20% PEG MME 1900 0.1M HEPES pH 7.5 0.5M potassium thiocyanate 30–40
2 20% PEG 20 000 0.1M HEPES pH 7.5 0.4M potassium nitrate 40
3 20% PEG MME 5000 — 0.5M potassium acetate 10–20
4 15% PEG 10 000 0.1M sodium acetate pH 4.6 0.3M magnesium formate 40
5 30% PEG MME 1900 — 0.3M magnesium formate 30
6 25% PEG 3350 0.1M sodium cacodylate pH 6.5 0.6M magnesium acetate 20
7 12% PEG 3350 0.1M MES pH 6.5 0.2M magnesium acetate,
50 mM magnesium chloride
200
† Longest dimension.
measured using a Rigaku R-AXIS IV++ imaging-plate area detector.
One crystal from the Topaz chip experiment and one crystal from the
hanging-drop experiment were evaluated at room temperature
(293 K) after mounting in quartz capillary tubes (Charles Supper
Company, Natick, MA, USA). All other X-ray diffraction analyses
were performed at 100 K on crystals harvested with nylon loops
(Hampton Research, San Diego, CA, USA) from the hanging-drop
experiments. These crystals were cryoprotected by dipping into
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Figure 2
Diffraction images. (a) Room temperature,6 A˚ resolution. (b) After cryoprotection, 4.3 A˚ resolution (Table 2). (c) After cryoprotection and dehydration, 3.7 A˚ resolution
(Table 2). The right panels show an enlargement of the the same portion of the left panels as indicated.
cryocooling solution for 30 s to 2 min followed by flash-cooling in a
nitrogen-gas stream. The cryocooling solution comprised 15% ethy-
lene glycol, 17% PEG 3350, 0.2Mmagnesium acetate, 0.1MMES pH
6.5 and 50 mM magnesium chloride. A CryoCool-LN2 (Cryo Indus-
tries, Manchester, NH, USA) was used for cooling crystals. The X-ray
diffraction data were integrated, processed and scaled using the
program HKL-2000 (Otwinowski & Minor, 1997).
2.4. Dehydration
For crystal dehydration (Heras et al., 2003; Heras & Martin, 2005),
crystals were transferred into a buffer comprising 25–30% PEG 3350,
0.2M magnesium acetate, 0.1M MES pH 6.5, 50 mM magnesium
chloride for 3 h, 1 d or 2 d. After dehydration, the crystals were
cryocooled in dehydration buffer also containing 15% ethylene glycol
and tested for diffraction quality as above. To confirm the reprodu-
cibility of the results shown in Fig. 2 and Table 2, we evaluated three
nondehydrated crystals, two crystals after 3 h dehydration, two
crystals after 1 d dehydration and two crystals after 2 d dehydration
(data not shown).
3. Results and discussion
Initial cocrystallization screening was carried out by free-interface
diffusion using Topaz crystallization-screening chips. This allowed 96
conditions to be assessed using just 3 ml of protein, where each well
contained 0.75–2.25 nl protein at three protein:precipitant ratios: 1:3,
1:1 and 3:1. After 3 d, crystals were observed in the protein wells of
the Topaz chip in six different conditions of the Optimix I screen
(Fig. 1, Table 1). All six conditions included PEG or PEG mono-
methyl ether (MME) as a precipitant. A crystal from condition 4
(Table 1; 40 mm in the longest dimension) was retrieved from the
chip for diffraction analysis, but no diffraction pattern could be
recorded. It was not clear whether the lack of diffraction was a
consequence of inherent disorder in the crystal or simply that the
crystal was too small for diffraction to be observed using the
laboratory X-ray facility. To address this question, larger crystals
were required.
All six successful Optimix I conditions were therefore translated
into the larger volume hanging-drop conditions with the aim of
growing larger crystals for diffraction analysis. The largest crystals
were found with 10–13% PEG 3350, 0.2M magnesium acetate, 0.1M
MES pH 6.5, 50 mM magnesium chloride, conditions which were
related to condition 6 from the free-interface diffusion results.
Crystals grew to dimensions of 0.2  0.2  0.2 mm over a period of
7 d using these conditions. These crystals belong to the cubic space
group P213 and diffract X-rays to a resolution of 6 A˚ at room
temperature (Fig. 2a; a = b = c = 174.5 A˚; mosaicity, 0.2) and 4.3 A˚ at
100 K (Fig. 2b; a = b = c = 172.5 A˚; mosaicity, 0.6) (Table 2). The
diffraction resolution of the crystals was considerably and repro-
ducibly improved by dehydrating the crystals prior to cryocooling.
Dehydration was achieved by placing the crystals in a solution
containing a higher concentration of the precipitant (25–30% PEG
3350) than that in which they were grown (10–13% PEG 3350; all
other components of the mother liquor remained the same; Heras et
al., 2003, Heras & Martin, 2005). The diffraction quality was tested
for crystals dehydrated for 3 h, 1 d and 2 d. Improvement in
diffraction resolution was observed only after the longer periods of 1
or 2 d. Crystals did not show any signs of cracking during dehydra-
tion. After cryocooling, the unit-cell volume of the crystals was
reduced by 3%. Dehydration reduced the unit-cell volume by a
further 3%. After dehydration and cryocooling, the diffraction
resolution of the crystals on the in-house X-ray equipment improved
to 3.7 A˚ resolution (Fig. 2c; a = b = c = 170.8 A˚; mosaicity, 0.4). The
3.7 A˚ resolution data set consists of 146 586 independent observa-
tions corresponding to 18 037 unique reflections and is 99.9%
complete to 3.7 A˚ with an Rmerge of 0.079 (0.521 in the highest reso-
lution shell; Table 2). Assuming the presence of two molecules in the
asymmetric unit, the crystal volume per unit molecular weight (VM) is
2.7 A˚3 Da1, with a solvent content of 53%, which is within the
normal range for protein crystals (Matthews, 1968).
In summary, we grew diffraction-quality crystals of Munc18c by
complexing it with an N-terminal peptide from syntaxin4, using free-
interface diffusion to screen nanolitre volumes initially, scaling up to
hanging-drop vapour diffusion to grow larger crystals and dehy-
drating the crystals prior to data measurement.
A further improvement in diffraction resolution was achieved
recently through the use of synchrotron radiation on the dehydrated
crystals, allowing determination of the structure by molecular
replacement (Hu et al., 2007). The structure solution revealed that the
crystals contained both Munc18c and the N-terminal peptide, thereby
confirming the role of the peptide, in combination with dehydration,
in improving the crystal quality.
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